ProfileGDS5822 / ILMN_2486858
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 18% 30% 21% 14% 11% 29% 23% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 112.518
GSM1276600PDAC Late Ablation Control 217.230
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 111.621
GSM1276603PDAC Late Ablation 210.114
GSM1276604PDAC Late Ablation 38.611
GSM1303940PDAC Late Ablation_anti-CTLA4 115.329
GSM1303941PDAC Late Ablation_anti-CTLA4 211.923
GSM1303942PDAC Late Ablation_anti-CTLA4 3